Immunology Subscribe to Immunology
Stem cell bodyguards: Rare immune cells keep blood stem cells youthful
ScienceDaily (Oct. 22, 2012) Hiding deep inside the bone marrow are special cells. They wait patiently for the hour of need, at which point these blood-forming stem cells can proliferate and differentiate into billions of mature blood immune cells to help the body cope with infection, for example, or extra red blood cells for low oxygen levels at high altitudes
Stem cell bodyguards: Rare immune cells keep blood stem cells youthful
ScienceDaily (Oct. 22, 2012) Hiding deep inside the bone marrow are special cells. They wait patiently for the hour of need, at which point these blood-forming stem cells can proliferate and differentiate into billions of mature blood immune cells to help the body cope with infection, for example, or extra red blood cells for low oxygen levels at high altitudes
Researchers study ‘ACT TIL’ approach to treating metastatic melanoma
ScienceDaily (Oct. 17, 2012) Researchers at Moffitt Cancer Center have carried out a clinical trial in which patients with metastatic melanoma were given chemotherapy and an immunotherapy of adoptive cell transfer (ACT) with tumor infiltrating lymphocytes (TIL).
Body’s own recycling system: Researchers discover ‘molecular emergency brake’ in charge of regulating self-digestion
ScienceDaily (Oct.
Kidney grafts function longer in Europe than in the United States
ScienceDaily (Oct. 12, 2012) Kidney transplants performed in Europe are considerably more successful in the long run than those performed in the United States.
Molecular basis of infection of tick-transmitted disease uncovered
ScienceDaily (Oct. 12, 2012) Virginia Commonwealth University School of Medicine researchers have identified the “keys” and “doors” of a bacterium responsible for a series of tick-transmitted diseases.
RNA-based therapy brings new hope for an incurable blood cancer
ScienceDaily (Oct. 10, 2012) Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, this disease is devastating, and new therapies are sorely needed
RNA-based therapy brings new hope for an incurable blood cancer
ScienceDaily (Oct. 10, 2012) Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, this disease is devastating, and new therapies are sorely needed
Immune system harnessed to improve stem cell transplant outcomes
ScienceDaily (Oct. 1, 2012) A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant by making the cancer cells easier targets for the immune system. Outlined in the British Journal of Hematology , the Phase II clinical trial was led by Amir Toor, M.D., hematologist-oncologist in the Bone Marrow Transplant Program and research member of the Developmental Therapeutics program at VCU Massey Cancer Center
Follow Us!